What is the current Global Advanced Therapy Medicinal Products (ATMPs) Market size?

The Global Advanced Therapy Medicinal Products (ATMPs) Market is projected to register a CAGR of 13% during the forecast period (2024-2029) Read More

Who are the key players in Global Advanced Therapy Medicinal Products (ATMPs) Market?

Novartis AG, Gilead Sciences, Inc., Bristol-Myers Squibb Company, Bluebird Bio, Inc. and Vericel Corporation are the major companies operating in the Global Advanced Therapy Medicinal Products (ATMPs) Market. Read More

Which is the fastest growing region in Global Advanced Therapy Medicinal Products (ATMPs) Market?

Asia-Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Global Advanced Therapy Medicinal Products (ATMPs) Market?

In 2024, the North America accounts for the largest market share in Global Advanced Therapy Medicinal Products (ATMPs) Market. Read More

What years does this Global Advanced Therapy Medicinal Products (ATMPs) Market cover?

The report covers the Global Advanced Therapy Medicinal Products (ATMPs) Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Global Advanced Therapy Medicinal Products (ATMPs) Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Advanced Therapy Medicinal Products Market

Advanced Therapy Medicinal Products Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The report covers Advanced Therapy Medicinal Products and the market is segmented by Therapy Type (Cell Therapy, Gene Therapy, CAR-T Therapy, Tissue Engineered Product) and Geography (North America, Europe, Asia-Pacific, Rest of the World). The market provides the value (in USD million) for the above-mentioned segments.

Advanced Therapy Medicinal Products Industry Overview

The Advanced Therapy Medicinal Products (ATMPs) market is currently fragmented in nature with the presence of several large to small- and medium-sized players. Some of the companies that are currently dominating the market are Novartis AG, Gilead Sciences Inc., JCR Pharmaceuticals Co. Ltd, Bristol-Myers Squibb Company, F. Hoffmann-La Roche Ltd, Bluebird Bio Inc., UniQure NV, Kolon TissueGene Inc., Vericel Corporation, and PHARMICELL Co. Ltd.